Table 2.
Available clinical data and mutation status of CRC patients involved in the study.
| Mutational status (KRAS/BRAF) | Number | Mutation type | Location | Hepatic metastasis |
|---|---|---|---|---|
| WT | 7 | // | Colon (n = 3) | 1 |
| Rect/RSJ (n = 3) | ||||
| Sigmoid (n = 1) | ||||
| KRAS12+ | 4 | KRAS12_G12D (n = 2) | Colon (n = 3) | 1* |
| KRAS12_G12V* (n = 2) | Sigmoid (n = 1) | |||
| KRAS13+ | 3 | KRAS13_G13D (n = 3) | Colon (n = 1) | 0 |
| Rect/RSJ (n = 1) | ||||
| Sigmoid (n = 1) | ||||
| BRAF+ | 3 | BRAF_V600E (n = 3) | Colon (n = 2) | 1 |
| Rect/RSJ (n = 1) | ||||
| KRAS12+BRAF+ | 1 | KRAS12_G12D+ BRAF_V600E (n = 1) | Sigmoid (n = 1) | 0 |
*The patient with hepatic metastasis presented KRAS12_G12V mutation.